{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:19:49Z","timestamp":1791508789467,"version":"4.3.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Interstitial cystitis\/bladder pain syndrome (IC\/BPS) is a challenging chronic inflammatory condition affecting the urinary bladder, with limited treatment options. This study aims to assess the clinical efficacy of repeated intravesical platelet-rich plasma (PRP) injections for promoting urothelial regeneration and reducing inflammation in patients with IC\/BPS and investigate its correlation with subjective and objective treatment-related outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Four monthly intravesical PRP injections were given to 98 patients with non-Hunner-type IC\/BPS. Treatment outcomes were assessed using a global response assessment (GRA) score 3 months posttreatment. In addition, clinical symptom scores, pain severity, voiding diary data, uroflowmetry parameters, and GRA scores were compared before and after treatment and between different treatment outcome groups (satisfactory: GRA\u22652 unsatisfactory: GRA&lt;2). Baseline urine biomarkers were analyzed to identify potential treatment outcome predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After four PRP injections, 54 (55.1%) patients reported satisfactory outcomes. Lower urinary tract symptoms, bladder pain, urinary frequency, anxiety, and flow rate significantly improved from baseline (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) in all patients, regardless of the treatment outcome. All patients experienced improved treatment outcomes and increased maximum bladder capacity with successive PRP treatments, and no major complications were reported. Urine biomarkers indicated elevated inflammation and oxidative stress biomarkers in patients with IC\/BPS compared to controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Repeated PRP injections are safe and effective for reducing symptoms and bladder pain and improving bladder capacity in a majority of IC\/BPS patients, with better outcomes observed in patients with a mild form of bladder inflammation. These results support PRP as a promising novel bladder therapy for IC\/BPS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_166_24","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T02:04:10Z","timestamp":1729044250000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis\/bladder pain syndrome"],"prefix":"10.4103","volume":"37","author":[{"given":"Wan-Ru","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"R1-20250103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JU.0000000000002756","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"208","author":"Clemens","year":"2022","journal-title":"J Urol"},{"key":"R2-20250103","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int J Urol"},{"key":"R3-20250103","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/antibiotics10101194","article-title":"Use of intravesical injections of platelet-rich plasma for the treatment of bladder pain syndrome:A comprehensive literature review","volume":"10","author":"Trama","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R4-20250103","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.urology.2016.08.029","article-title":"Urothelial functional protein and sensory receptors in patients with interstitial cystitis\/bladder pain syndrome with and without Hunner's lesion","volume":"98","author":"Jhang","year":"2016","journal-title":"Urology"},{"key":"R5-20250103","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.juro.2013.11.099","article-title":"Segmental hyperalgesia to mechanical stimulus in interstitial cystitis\/bladder pain syndrome:Evidence of central sensitization","volume":"191","author":"Lai","year":"2014","journal-title":"J Urol"},{"key":"R6-20250103","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/bph.12958","article-title":"Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels","volume":"172","author":"Coelho","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R7-20250103","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41585-023-00850-y","article-title":"Mechanisms of oxidative stress in interstitial cystitis\/bladder pain syndrome","volume":"21","author":"Mohammad","year":"2024","journal-title":"Nat Rev Urol"},{"key":"R8-20250103","doi-asserted-by":"crossref","first-page":"344","DOI":"10.14712\/23362936.2023.27","article-title":"Potential mechanism of platelet-rich plasma treatment on testicular problems related to diabetes mellitus","volume":"124","author":"Hermilasari","year":"2023","journal-title":"Prague Med Rep"},{"key":"R9-20250103","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.3390\/ijms21207794","article-title":"Platelet-rich plasma:New performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R10-20250103","doi-asserted-by":"crossref","first-page":"e19452","DOI":"10.1016\/j.heliyon.2023.e19452","article-title":"Therapeutic role of mesenchymal stem cells and platelet-rich plasma on skin burn healing and rejuvenation:A focus on scar regulation, oxido-inflammatory stress and apoptotic mechanisms","volume":"9","author":"Tammam","year":"2023","journal-title":"Heliyon"},{"key":"R11-20250103","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/nau.23898","article-title":"Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-a prospective clinical trial","volume":"38","author":"Jhang","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R12-20250103","doi-asserted-by":"crossref","first-page":"853776","DOI":"10.3389\/fphar.2022.853776","article-title":"Therapeutic efficacy of intravesical platelet-rich plasma injections for interstitial cystitis\/bladder pain syndrome-a comparative study of different injection number, additives and concentrations","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R13-20250103","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1038\/s41598-020-72292-0","article-title":"Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci Rep"},{"key":"R14-20250103","doi-asserted-by":"crossref","first-page":"23259671221088820","DOI":"10.1177\/23259671221088820","article-title":"A Systematic Review on the Effect of Common Medications on Platelet Count and Function:Which Medications Should Be Stopped Before Getting a Platelet-Rich Plasma Injection?","volume":"10","author":"Kao","year":"2022","journal-title":"Orthop J Sports Med"},{"key":"R15-20250103","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/JCMA.0000000000000498","article-title":"Cystoscopic characteristic findings of interstitial cystitis and clinical implications in women with refractory interstitial cystitis:A prospective, multicenter study","volume":"84","author":"Tsai","year":"2021","journal-title":"J Chin Med Assoc"},{"issue":"Suppl 11","key":"R16-20250103","first-page":"S467","article-title":"Measures of anxiety:State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A)","volume":"63","author":"Julian","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R17-20250103","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/biomedicines10051149","article-title":"Use of urinary cytokine and chemokine levels for identifying bladder conditions and predicting treatment outcomes in patients with interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Yu","year":"2022","journal-title":"Biomedicines"},{"key":"R18-20250103","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/biomedicines10102380","article-title":"Current understanding of the pathophysiology and novel treatments of interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Jhang","year":"2022","journal-title":"Biomedicines"},{"key":"R19-20250103","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1097\/01.ju.0000180417.11976.99","article-title":"Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis","volume":"174","author":"Zhang","year":"2005","journal-title":"J Urol"},{"key":"R20-20250103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/tcmj.tcmj_172_23","article-title":"Cystoscopic characteristic findings of interstitial cystitis and clinical implications","volume":"36","author":"Yu","year":"2024","journal-title":"Tzu Chi Med J"},{"key":"R21-20250103","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/cells11030552","article-title":"Oxidative stress in human pathology and aging:Molecular mechanisms and perspectives","volume":"11","author":"Hajam","year":"2022","journal-title":"Cells"},{"key":"R22-20250103","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/toxins11090510","article-title":"Botulinum neurotoxin a intravesical injections in interstitial cystitis\/bladder painful syndrome:A systematic review with meta-analysis","volume":"11","author":"Giannantoni","year":"2019","journal-title":"Toxins (Basel)"},{"key":"R23-20250103","doi-asserted-by":"crossref","first-page":"3331024221141683","DOI":"10.1177\/03331024221141683","article-title":"OnabotulinumtoxinA effects on trigeminal nociceptors","volume":"43","author":"Moore","year":"2023","journal-title":"Cephalalgia"},{"key":"R24-20250103","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/toxins16020074","article-title":"Intravesical botulinum toxin injection plus hydrodistention is more effective in patients with bladder pain-predominant interstitial cystitis\/bladder pain syndrome","volume":"16","author":"Yu","year":"2024","journal-title":"Toxins (Basel)"},{"key":"R25-20250103","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/ijms23020890","article-title":"Cytokine profiling and intra-articular injection of autologous platelet-rich plasma in knee osteoarthritis","volume":"23","author":"Riewruja","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R26-20250103","doi-asserted-by":"crossref","first-page":"e23420","DOI":"10.1002\/jbt.23420","article-title":"Platelet-rich plasma ameliorates neurotoxicity induced by silver nanoparticles in male rats via modulation of apoptosis, inflammation, and oxidative stress","volume":"37","author":"Elmongy","year":"2023","journal-title":"J Biochem Mol Toxicol"},{"key":"R27-20250103","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14712598.2017.1259409","article-title":"Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration","volume":"17","author":"S\u00e1nchez","year":"2017","journal-title":"Expert Opin Biol Ther"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_166_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:21:32Z","timestamp":1787836892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_166_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_166_24","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"2024-06-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}